Does Nurse Semi Structured Interview Added to a rTMS Improve Patients With Major Depressive Disorder?
DESTIMCARE
Does Nurse Semi - Structured Interview Added to a Repeated Transcranial Magnetic Stimulation Improve Patients With Major Depressive Disorder? A Single Center Study, Randomized, Controlled and Single Blind
1 other identifier
interventional
50
1 country
1
Brief Summary
Repeated Transcranial Magnetic Stimulation - R.TMS - is currently part of the treatment for depressive illness. This non-invasive technique is designed to stimulate certain areas of the cerebral cortex involved in this pathology. FDA approved this treatment in routine for depressive illness. R.TMS still remains in assessment. Due to the heterogeneity of methods and the weakness of the cohorts therapeutic superiority can not concluded . Stimulation parameters remain numerous even if a consensus is beginning to emerge. The therapeutic target is the left dorso - lateral prefrontal cortex. The lack of efficacy is probably due of the inaccuracy. The empirically location of the target does not take into account the inter-individual anatomical differences. The neuronavigation is becoming widespread in routine clinical practice. The referent nurse stays with the patient all along the rTMS sessions. His role is to set up treatment, to ensure the safety and the well-being of the patient. An rTMS session is an average of 30 minutes and is a very special moment to create a specific therapeutic relationship. No study was conducted to evaluate the therapeutic relationship. The assumption is made that rTMS with a semi - structured interview provides a qualitative and quantitative clinical response greater than a semi - structured rTMS without this nursing care. The investigators therefore propose to patients not receiving a semi-structured interview to listen to music with eyes closed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 12, 2018
CompletedFirst Posted
Study publicly available on registry
February 19, 2018
CompletedStudy Start
First participant enrolled
March 19, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 6, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 6, 2023
CompletedJanuary 20, 2023
January 1, 2023
4.8 years
February 12, 2018
January 19, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
score of the Montgomery-Asberg Depression Rating Scale
The ratings should be based on a clinical interview moving from broadly phrased questions about symptoms to more detailed ones which allow a precise rating of severity. The rater must decide whether the rating lies on the defined scale steps (0, 2, 4, 6) or between them (1, 3, 5). It is important to remember that it is only rare occasions that a depressed patient is encountered who cannot be rated on the items in the scale. If definite answers cannot be elicited from the patients, all relevant clues as well as information from other sources should be used as a basis for the rating in line with customary clinical practice.
day 44
Study Arms (2)
R.TMS + nurse semi-structured interview
EXPERIMENTALRepeated Transcranial Magnetic Stimulation sessions associated with nurse semi-structured interview
R.TMS + Music & Relaxation
SHAM COMPARATORRepeated Transcranial Magnetic Stimulation sessions associated with music listening \& relaxation with eyes closed
Interventions
The first session of rTMS is D1. From the first meeting to D14 semi -structured interviews are set up
The first session of rTMS is D1. From the first meeting to D14 music \& relaxation with eyes closed sessions are set up
Eligibility Criteria
You may qualify if:
- Patients volunteers aged 18 to 70,
- With the diagnosis of major depression, recurrent under the criteria of DSM.V,
- With an unmodified antidepressant treatment for 3 weeks,
- With a MADRS score greater than or equal to 21,
- With or without neuronavigated rTMS sessions,
- Informed and who have signed a consent.
You may not qualify if:
- Patients with psychotic symptoms,
- With alcohol dependence or other substances abuse,
- With the strength criteria defined by the V stage for Classification of Thase \& Rush,
- Hospitalized without consent / or under legal protection for major.
- With a high risk of suicide - item 10 of the MADRS\> 3 in the absence of hospitalization,
- With contraindications to the practice of MRI or rTMS due to previous seizures, neurological disorders and / or neurosurgical, metal prosthetic presence or foreign bodies pacemaker type intraocular ferromagnetic material,
- Aged over 70 years due to cortical alteration,
- Pregnancy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Rennes University Hospitallead
- Ministry of Health, Francecollaborator
Study Sites (1)
CHGR
Rennes, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dominique Drapier, MD
Centre Hospitalier Guillaume Régnier,
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 12, 2018
First Posted
February 19, 2018
Study Start
March 19, 2018
Primary Completion
January 6, 2023
Study Completion
January 6, 2023
Last Updated
January 20, 2023
Record last verified: 2023-01